TBX1 and familial pancreatic carcinoma: We observed that CM from QYHJ-treated CAFs exhibited decreased migration and invasion-promoting capacities compared with that of control-treated CAFs (Figure 2 and Figure S2), these results suggested that QYHJ treatment might suppress pancreatic cancer cell migration and invasion through targeting CAFs.